BR0007491A - Uso de 3-isoxazolidinonas e ácidos hidroxilâmicospara o tratamento de infecções - Google Patents
Uso de 3-isoxazolidinonas e ácidos hidroxilâmicospara o tratamento de infecçõesInfo
- Publication number
- BR0007491A BR0007491A BR0007491-8A BR0007491A BR0007491A BR 0007491 A BR0007491 A BR 0007491A BR 0007491 A BR0007491 A BR 0007491A BR 0007491 A BR0007491 A BR 0007491A
- Authority
- BR
- Brazil
- Prior art keywords
- hydroxylamic
- isoxazolidinones
- acids
- treat infections
- infections
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19900907 | 1999-01-13 | ||
DE19903666A DE19903666A1 (de) | 1999-01-13 | 1999-01-30 | Arzneimittel mit einem Gehalt an 3-Isoxazolidinonen und Hydroxylaminsäuren als Wirkstoff und ihre Verwendung |
PCT/EP2000/000165 WO2000041473A2 (de) | 1999-01-13 | 2000-01-12 | Verwendung von 3-isoxazolidinonen und hydroxylaminsäuren zur behandlung von infektionen |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0007491A true BR0007491A (pt) | 2001-11-20 |
Family
ID=26051290
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0007491-8A BR0007491A (pt) | 1999-01-13 | 2000-01-12 | Uso de 3-isoxazolidinonas e ácidos hidroxilâmicospara o tratamento de infecções |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP1143941A3 (no) |
JP (1) | JP2002534440A (no) |
CN (1) | CN1342078A (no) |
AU (1) | AU2436600A (no) |
BR (1) | BR0007491A (no) |
CA (1) | CA2360366A1 (no) |
CZ (1) | CZ20012380A3 (no) |
HU (1) | HUP0105412A2 (no) |
IL (1) | IL143795A0 (no) |
NO (1) | NO20013464L (no) |
PL (1) | PL350128A1 (no) |
SK (1) | SK9502001A3 (no) |
TR (1) | TR200102019T2 (no) |
WO (1) | WO2000041473A2 (no) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1443930A1 (en) | 2001-10-25 | 2004-08-11 | AstraZeneca AB | Isoxazoline derivatives useful as antimicrobials |
GB202209172D0 (en) * | 2022-06-22 | 2022-08-10 | Syngenta Crop Protection Ag | Improvements in or relating to organic compounds |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL45174A (en) * | 1973-08-10 | 1976-12-31 | Merck & Co Inc | Antibacterial preparations containing a compound of the type 3-fluoro-D-alanine and a cyclocarrin compound that is converted in the nitrogen atom |
US3911007A (en) * | 1974-08-08 | 1975-10-07 | Searle & Co | N-substituted N-benzyloxy-2-methyl-2-(4-halophenoxy)propionamides |
FR2290442A1 (fr) * | 1974-11-06 | 1976-06-04 | Aries Robert | Nouvelles rifamycines |
EP0219923B1 (en) * | 1985-04-30 | 1992-09-02 | Takeda Chemical Industries, Ltd. | Antibiotic derivatives, their production and use |
GB8531838D0 (en) * | 1985-12-30 | 1986-02-05 | Wellcome Found | Aryl derivatives |
JPS63119462A (ja) * | 1986-11-05 | 1988-05-24 | Takeda Chem Ind Ltd | 五員環n−スルホ化合物 |
JPS63119476A (ja) * | 1986-11-05 | 1988-05-24 | Takeda Chem Ind Ltd | イソキサゾリドン誘導体 |
US5288896A (en) * | 1992-01-15 | 1994-02-22 | Warner-Lambert Company | 3,5-di-t-butyl-4-hydroxylphenylmethylhydroxylamines and their derivatives, pharmaceutical compositions, and methods of use therefor |
US5652262A (en) * | 1993-03-16 | 1997-07-29 | British Biotech Pharmaceutical, Ltd. | Hydroxamic acid derivatives as metalloproteinase inhibitors |
CA2170158A1 (en) * | 1993-08-23 | 1995-03-02 | Roy A. Black | Inhibitors of tnf-alpha secretion |
GB9401129D0 (en) * | 1994-01-21 | 1994-03-16 | British Bio Technology | Hydroxamic acid derivatives as metalloproteinase inhibitors |
WO1996013263A2 (en) * | 1994-11-01 | 1996-05-09 | Research Corporation Technologies, Inc. | Methods of treatment of viral disease with inhibitors of sphingolipid biosynthesis |
US5919790A (en) * | 1996-10-11 | 1999-07-06 | Warner-Lambert Company | Hydroxamate inhibitors of interleukin-1β converting enzyme |
US6251913B1 (en) * | 1997-03-28 | 2001-06-26 | Zeneca Limited | Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor |
AUPO721997A0 (en) * | 1997-06-06 | 1997-07-03 | Queensland Institute Of Medical Research, The | Anticancer compounds |
-
2000
- 2000-01-12 IL IL14379500A patent/IL143795A0/xx unknown
- 2000-01-12 AU AU24366/00A patent/AU2436600A/en not_active Abandoned
- 2000-01-12 CZ CZ20012380A patent/CZ20012380A3/cs unknown
- 2000-01-12 CA CA002360366A patent/CA2360366A1/en not_active Abandoned
- 2000-01-12 CN CN00802779A patent/CN1342078A/zh active Pending
- 2000-01-12 JP JP2000593097A patent/JP2002534440A/ja active Pending
- 2000-01-12 WO PCT/EP2000/000165 patent/WO2000041473A2/de not_active Application Discontinuation
- 2000-01-12 SK SK950-2001A patent/SK9502001A3/sk unknown
- 2000-01-12 EP EP00902582A patent/EP1143941A3/de not_active Withdrawn
- 2000-01-12 TR TR2001/02019T patent/TR200102019T2/xx unknown
- 2000-01-12 PL PL00350128A patent/PL350128A1/xx not_active Application Discontinuation
- 2000-01-12 HU HU0105412A patent/HUP0105412A2/hu unknown
- 2000-01-12 BR BR0007491-8A patent/BR0007491A/pt not_active Application Discontinuation
-
2001
- 2001-07-12 NO NO20013464A patent/NO20013464L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CZ20012380A3 (cs) | 2002-01-16 |
NO20013464L (no) | 2001-09-12 |
PL350128A1 (en) | 2002-11-04 |
NO20013464D0 (no) | 2001-07-12 |
WO2000041473A3 (de) | 2001-11-29 |
CA2360366A1 (en) | 2000-07-20 |
WO2000041473A2 (de) | 2000-07-20 |
AU2436600A (en) | 2000-08-01 |
EP1143941A2 (de) | 2001-10-17 |
EP1143941A3 (de) | 2002-02-06 |
HUP0105412A2 (hu) | 2002-05-29 |
TR200102019T2 (tr) | 2002-04-22 |
SK9502001A3 (en) | 2002-05-09 |
JP2002534440A (ja) | 2002-10-15 |
IL143795A0 (en) | 2002-04-21 |
CN1342078A (zh) | 2002-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9909668A (pt) | Uso de compostos de organofósforo para o tratamento terapêutico e profilático de infecções | |
NO20025450D0 (no) | Ny farmasöytisk sammensetning | |
BR0116370A (pt) | Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente. | |
EA200100524A1 (ru) | Амиды антраниловой кислоты и их применение в качестве лекарственных средств | |
DK1411932T3 (da) | Kombinationsterapi med substituerede oxazolidinoner | |
WO2001045679A3 (de) | Verwendung von chemotherapeutika zur topischen behandlung | |
BR0013010A (pt) | Formulação de cloreto de sódio de moxifloxacina | |
BR0107628A (pt) | l,2-diarilbenzimidazóis para tratamento de doenças que estão associadas a uma ativação microglial | |
BR9712141A (pt) | Aplicação de 1-hifróxi-2-piridonas para tratamento de infecções cutâneas. | |
EA200400214A1 (ru) | Азитромицин в виде разовой дозы | |
RS8504A (en) | Novel cyclohexil sulphones | |
PT1140113E (pt) | Utilizacao de bisfosfonatos para profilaxia e tratamento de processos infecciosos | |
SE0004101D0 (sv) | New use | |
BR0006301A (pt) | Macrólidos antibacterianos e pró-cinéticos | |
BR0015722A (pt) | Uso de derivados de pleuromutilina para tratamento transdérmico de doenças bacterianas | |
DE50113974D1 (de) | Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen | |
BR9913990A (pt) | Uso de compostos organofosforados para a produção de preparações farmacêuticas para o tratamento terapêutico e profilático de infecções ou como um fungicida, bactericida ou herbicida em plantas | |
BR0007491A (pt) | Uso de 3-isoxazolidinonas e ácidos hidroxilâmicospara o tratamento de infecções | |
ATE344662T1 (de) | Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen | |
ATE317263T1 (de) | Diphosphonat derivate von therapeutisch wirksamen stoffen | |
BR0005061A (pt) | Secreção de ácido gástrico | |
ATE241640T1 (de) | Fusidinsäure-derivate | |
IT1265647B1 (it) | Composizione farmaceutiche topiche per le allergie respiratorie | |
ATE308895T1 (de) | Behandlung von infektionen in tieren | |
EA200100768A1 (ru) | Применение 3-изоксазолидинонов и гидроксиаминокислот для лечения инфекций |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA10 | Dismissal: dismissal - article 33 of industrial property law | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |